The FDA flagged at least five cases of severe or very severe RSV lower respiratory tract infections in infants immunized with ...

Norovirus vaccines face significant hurdles, with virtually no success from past efforts from HilleVax and Vaxxart. But ...

MinterEllison has advised Moderna in relation to its new mRNA manufacturing facility – a facility described by the firm as ...

BofA reinstated coverage of Moderna (MRNA) with an Underperform rating and $41 price target calling it “a tough time to be a vaccines ...

CEO Stéphane Bancel said that he plans to address any partisan hurdles with the incoming Trump administration’s vaccine and ...

Trump said during a rally in late October that he would let Kennedy “go wild” on healthcare in the country, and vaccine ...

Drug manufacturers saw their stock prices fall on Friday after vaccine skeptic Robert F. Kennedy Jr. was announced as Trump's ...

Moderna (MRNA) stock has fallen 71% over the last six months. While there’s still potential for near-term revenue tailwinds ...

The S&P 500 fell 0.3% on Tuesday, Dec. 10, as the cooldown from last week's record-setting rally continued ahead of key ...

Shares of Moderna Inc. MRNA slid 2.23% to $41.63 Wednesday, on what proved to be an all-around great trading session for the ...

Moderna stock remains under pressure with analysts projecting steep losses in the fourth quarter. Is MRNA stock a sell today? The S&P 500 has hit record levels this year and many stocks have ...